Inceptionr LLC Invests $628,000 in Colgate-Palmolive Company $CL

Inceptionr LLC acquired a new stake in shares of Colgate-Palmolive Company (NYSE:CL) in the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor acquired 7,855 shares of the company’s stock, valued at approximately $628,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Copia Wealth Management acquired a new position in Colgate-Palmolive during the 3rd quarter valued at about $29,000. Vermillion & White Wealth Management Group LLC grew its stake in shares of Colgate-Palmolive by 86.1% during the second quarter. Vermillion & White Wealth Management Group LLC now owns 335 shares of the company’s stock worth $30,000 after acquiring an additional 155 shares during the last quarter. Cloud Capital Management LLC purchased a new stake in shares of Colgate-Palmolive during the third quarter worth about $30,000. MTM Investment Management LLC purchased a new position in shares of Colgate-Palmolive in the 2nd quarter valued at approximately $39,000. Finally, Louisbourg Investments Inc. raised its holdings in shares of Colgate-Palmolive by 94.7% in the third quarter. Louisbourg Investments Inc. now owns 514 shares of the company’s stock worth $41,000 after buying an additional 250 shares during the last quarter. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several analysts have recently commented on CL shares. Royal Bank Of Canada raised shares of Colgate-Palmolive from a “sector perform” rating to an “outperform” rating and set a $88.00 price objective on the stock in a report on Tuesday, December 9th. Morgan Stanley boosted their target price on shares of Colgate-Palmolive from $87.00 to $100.00 and gave the stock an “overweight” rating in a research note on Monday, February 2nd. Deutsche Bank Aktiengesellschaft boosted their target price on Colgate-Palmolive from $83.00 to $90.00 and gave the stock a “hold” rating in a report on Monday, February 2nd. Argus reaffirmed a “hold” rating on shares of Colgate-Palmolive in a research report on Thursday, December 11th. Finally, Citigroup raised their price target on shares of Colgate-Palmolive from $95.00 to $105.00 and gave the company a “buy” rating in a research report on Monday, February 2nd. Eleven investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $94.75.

Colgate-Palmolive Stock Performance

NYSE CL opened at $92.45 on Wednesday. The company has a debt-to-equity ratio of 18.82, a current ratio of 0.83 and a quick ratio of 0.54. The company has a market capitalization of $74.52 billion, a P/E ratio of 35.29, a PEG ratio of 4.17 and a beta of 0.28. The business has a 50 day moving average price of $89.50 and a 200 day moving average price of $83.13. Colgate-Palmolive Company has a 1-year low of $74.54 and a 1-year high of $99.33.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, January 30th. The company reported $0.95 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.91 by $0.04. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.The business had revenue of $5.23 billion for the quarter, compared to the consensus estimate of $5.13 billion. During the same period in the prior year, the business earned $0.91 earnings per share. The business’s revenue was up 5.8% on a year-over-year basis. Sell-side analysts expect that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Insider Transactions at Colgate-Palmolive

In related news, insider Sally Massey sold 15,851 shares of the business’s stock in a transaction dated Thursday, February 5th. The stock was sold at an average price of $95.03, for a total value of $1,506,320.53. Following the transaction, the insider owned 13,751 shares in the company, valued at approximately $1,306,757.53. The trade was a 53.55% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider John Hazlin sold 20,989 shares of the company’s stock in a transaction dated Tuesday, February 10th. The shares were sold at an average price of $94.25, for a total transaction of $1,978,213.25. Following the completion of the sale, the insider owned 17,645 shares in the company, valued at approximately $1,663,041.25. This trade represents a 54.33% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 184,683 shares of company stock valued at $17,486,693. Insiders own 0.41% of the company’s stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.